HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $70 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 86.3%

Neg 0% Neu 86.3% Pos 0%

HC Wainwright & Co. analyst Emily Bodnar reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $70 price target.